Art

J-GLOBAL ID：201902230958782530   Reference number：19A0500891

Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects

セツキシマブ副作用の候補剤によるヒト口腔癌細胞の増殖抑制【JST・京大機械翻訳】

Author (14)： Uzawa Katsuhiro (Department of Oral Science, Graduate School of Medicine, Chiba University, 1-8- 1 Inohana, Chuo-ku, Chiba 260-8670, Japan) ,  Uzawa Katsuhiro (Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan) ,  Kasamatsu Atsushi (Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan) ,  Saito Tomoaki (Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan) ,  Kita Akihiro (Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan) ,  Sawai Yuki (Department of Oral Science, Graduate School of Medicine, Chiba University, 1-8- 1 Inohana, Chuo-ku, Chiba 260-8670, Japan) ,  Toeda Yuriko (Department of Oral Science, Graduate School of Medicine, Chiba University, 1-8- 1 Inohana, Chuo-ku, Chiba 260-8670, Japan) ,  Koike Kazuyuki (Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan) ,  Nakashima Dai (Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan) ,  Endo Yosuke (Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan) ,  Shiiba Masashi (Department of Medical Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan) ,  Takiguchi Yuichi (Department of Medical Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan) ,  Tanzawa Hideki (Department of Oral Science, Graduate School of Medicine, Chiba University, 1-8- 1 Inohana, Chuo-ku, Chiba 260-8670, Japan) ,  Tanzawa Hideki (Department of Dentistry and Oral-Maxillofacial Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan)
Material： Experimental Cell Research  (Exp Cell Res)
Volume： 376  Issue： 2  Page： 210-220  Publication year： 2019 
JST Material Number： B0313A  ISSN： 0014-4827  CODEN： ECREAL  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Cetuximab, an inhibitor of the...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0500891&from=J-GLOBAL&jstjournalNo=B0313A") }}

Thesaurus term： *side effect ,  toxicity ,  *human ,  *inhibition of multiplication ,  therapeutic planning ,  p38 MAP kinase ,  EGF receptor ,  HEK293 cell ,  Fetus ,  keratinocyte ,  Flagellin ,  P38 ,  Proto-Oncogene Proteins c-fos
Semi thesaurus term： 阻害剤 ,  *セツキシマブ , 【Automatic Indexing@JST】

Author keywords (6)： Cetuximab side effects ,  p38 ,  TRPM6 ,  SB203580 ,  Flavagline ,  Tumor growth suppression

JST classification (1)： Cell physiology in general  (EF02010S)

Terms in the title (6)： セツキシマブ ,  副作用 ,  ヒト ,  口腔 ,  癌細胞 ,  増殖抑制